| Life prolonging of disease management programs in patients with type 2 diabetes is cost-effective. | |
| | |
MedLine Citation:
|
PMID: 22004943 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
AIM: Our objective was to examine the cost-effectiveness of disease management programs (DMPs) for type 2 diabetes mellitus (T2DM) taking into account their life prolonging effect. METHODS: We compared real life costs in 19,888 propensity score matched pairs of T2DM DMP participants and T2DM patients in routine care (RC) according to sickness funds data. We estimated mean annual costs for survivors, last year of life costs for decedents, the influence of ageing on costs, incremental cost-effectiveness ratio and effects on hospitalization. RESULTS: Annual costs for survivors were 3,318€ (DMP) and 3,570€ (RC). The mean costs in the last year of life were 16,911€ (DMP) and 15,763€ (RC). Ageing had a cost triggering effect for survivors (30€/36€ per year in DMP-/RC-group; p<0.001) and a cost decreasing effect in the last year of life (546€/483€ per year in DMP-/RC-group; p<0.001). The incremental cost-effectiveness ratio of the DMP vs. RC was -74€ per life-year gained. Hospitalizations increased with age in case of survival and decreased with age in case of death but were always lower in the DMP-group. CONCLUSION: Despite increase in costs due to longer life DMPs are cost-effective. |
| | |
Authors:
|
A Drabik; G Büscher; P T Sawicki; K Thomas; C Graf; D Müller; S Stock |
Related Documents
:
|
21922033 - Two sides of the same coin: learning via positive and negative reinforcers in the human... 6909023 - Programs sargon and delta: two new principles for the automated analysis of the visual ... 16799283 - Bringing ethics education to the clinical years: ward ethics sessions at the university... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-10-15 |
Journal Detail:
|
Title: Diabetes research and clinical practice Volume: - ISSN: 1872-8227 ISO Abbreviation: - Publication Date: 2011 Oct |
Date Detail:
|
Created Date: 2011-10-18 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8508335 Medline TA: Diabetes Res Clin Pract Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved. |
Affiliation:
|
Institute of Health Economics and Clinical Epidemiology, University Hospital Cologne, Gleueler Straße 176-178, 50935 Köln, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Vaccination with IA-2 autoantigen can prevent late prediabetic nonobese diabetic mice from developin...
Next Document: Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, is...